OTCMKTS:CNTMF - Cansortium Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.20
  • Forecasted Upside: 63.27 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.74
▼ -0.011 (-1.47%)

This chart shows the closing price for CNTMF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cansortium Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNTMF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNTMF

Analyst Price Target is $1.20
▲ +63.27% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Cansortium in the last 3 months. The average price target is $1.20, with a high forecast of $1.20 and a low forecast of $1.20. The average price target represents a 63.27% upside from the last price of $0.74.

This chart shows the closing price for CNTMF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Cansortium. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/10/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/29/2021Canaccord GenuityReiterated RatingBuy$1.20
6/3/2020Canaccord GenuityReiterated RatingBuy$0.70
6/28/2019Canaccord GenuityInitiated CoverageBuy
(Data available from 12/5/2016 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/9/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2021
  • 4 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/6/2021
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/6/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/5/2021
  • 3 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/5/2021

Current Sentiment

  • 3 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Cansortium logo
Cansortium, Inc. engages in the production and sale of medical cannabis. The firm focuses on oil extracted and derived products for use by medical patients. Its objective is to invest in and develop multiple jurisdictions for the vertical integrated approach for the sale and distribution of processed cannabis oil in medical use frameworks. The company was founded by Jose Jaiver Hidalgo and Henry Batievsky on August 31, 2018 and is headquartered in Miami, FL.
Read More

Today's Range

Now: $0.74
Low: $0.71
High: $0.75

50 Day Range

MA: $0.74
Low: $0.66
High: $0.90

52 Week Range

Now: $0.74
Low: $0.33
High: $1.35

Volume

81,199 shs

Average Volume

270,535 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Cansortium?

The following equities research analysts have issued stock ratings on Cansortium in the last year: Canaccord Genuity.
View the latest analyst ratings for CNTMF.

What is the current price target for Cansortium?

1 Wall Street analysts have set twelve-month price targets for Cansortium in the last year. Their average twelve-month price target is $1.20, suggesting a possible upside of 63.3%. Canaccord Genuity has the highest price target set, predicting CNTMF will reach $1.20 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of $1.20 for Cansortium in the next year.
View the latest price targets for CNTMF.

What is the current consensus analyst rating for Cansortium?

Cansortium currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CNTMF will outperform the market and that investors should add to their positions of Cansortium.
View the latest ratings for CNTMF.

How do I contact Cansortium's investor relations team?

Cansortium's physical mailing address is 82 NE 26th Street, Miami, FL 33137. The company's listed phone number is (305) 902-2720. The official website for Cansortium is www.cansortium.com.